The Story Behind Warsaw Genomics’ Automated RNAdvance Viral Extraction Workflow

Warsaw Genomics consists of talented scientists whose primary mission is to study errors in the human genome for cancer, metabolic, and rare diseases using modern genetic analysis tools.

Warsaw Genomics Testimonial with Dr. Monika KolanowskaBefore the global outbreak of SARS-CoV-2 in 2020, Warsaw Genomics focused on their primary mission to study the genomic errors responsible for cancer, metabolic, and rare diseases in humans. Their team of talented scientists uses modern tools of genetic analysis and advanced bioinformatics in this pursuit.

The pandemic, however, shifted their priorities. In March, Warsaw Genomics recognized the rapidly growing demand for viral testing in their home country of Poland and started to expand their capacity for RNA analysis. They approached Beckman Coulter Life Sciences for support, and the two groups worked together to build an extraction pipeline using RNAdvance Viral chemistry and Biomek automation in just a few weeks.

We interviewed Dr. Monika Kolanowska, Scientist and Laboratory Team Leader at Warsaw Genomics, to discuss the collaboration with Beckman Coulter and how they overcame the challenges associated with the accelerated scale-up. The first major challenge was throughput. At the beginning of the project, Dr. Kolanowska’s lab set a goal of performing 2,000 extractions per day. Even with scientists working around the clock, it was impossible to achieve this target using a manual approach. An automated solution was necessary. Beckman Coulter recommended using the RNAdvance Viral extraction kit, bead-based chemistry that uses Solid Phase Reversible Immobilization or SPRI technology. It showed significant agreement with positive and negative SARS-CoV-2 samples, and its methods can be readily automated.

Warsaw Genomics Testimonial LogosCompared to an existing extraction kit used in the lab, RNAdvance Viral showed significantly higher detection sensitivity, with Ct values of 5 to 10 cycles lower in quantitative PCR assays.

Beckman Coulter also proposed using Biomek i5 liquid handlers to automate the extraction process. The resulting solution runs with minimal user interaction and takes about 1 hour to extract RNA from 192 samples. With the help of automation, the lab is able to “sustain the same time frame during the whole day and, as a consequence, lets (us) run more samples daily,” said Dr. Kolanowska. Thanks to this efficient pipeline, Warsaw Genomics recently announced the ability to process 3,500 SARS- CoV-2 viral RNA samples daily.

Another challenge that Dr. Kolanowska and her group faced was building an automated RNA extraction pipeline from scratch in a short time frame. The Beckman team shared the same urgency, and the RNAdvance Viral extraction kits and a Biomek liquid handler were delivered and installed in just a few days. The first round of extraction tests was successfully completed within three days after instrument installation.

The Beckman support team stays in touch with Warsaw Genomics so they can respond quickly whenever there is a need. Dr. Kolanowska says she “really appreciates all your help and support for us” and believes that with an ongoing partnership with Beckman Coulter Life Sciences that “we’ll figure out all the obstacles we’re running into.”

From this experience, Dr. Kolanowska mentioned that her key learning is “to understand how we can use Biomek workstations for different purposes. Now, I understand very (clearly) the specifications of our Biomeks and know how to use them in the future for different goals.”

Beckman Coulter is honored to be a part of the scientific community that fights the current COVID-19 pandemic. We appreciate the opportunity to collaborate with Warsaw Genomics to deliver an outstanding automation RNA extraction solution.

If you are interested in knowing more about Warsaw Genomics, please visit their website. And you can connect with their talented scientists on LinkedIn.

Warsaw Genomics Testimonial Workflow and Automation

 

Product Information: Viral RNA Extraction Reagent Kits

RNAdvance Viral Reagent Kit - 768 Preps
Part number: C63510

RNAdvance Viral reagent kit isolates RNA from Saliva and Swab Transport Media

 

RNAdvance Viral XP Reagent Kit - 1056 Preps
Part number: C59543

RNA Isolation from Viral Samples RNAdvance Viral XP Reagent Kit

RNAdvance Viral XP is listed as an extraction method for use with the Centers for Disease Control’s EUA-authorized COVID-19 test referenced in FDA’s FAQ on testing for SARS-CoV-2. Other than this designation, RNAdvance Viral XP is for research use, and not intended for diagnostic purposes.
RNAdvance Viral is for research use.

Related Webinar

Watch the collaboration between Beckman Coulter Life Sciences and Integrated DNA Technologies (IDT) for the solutions to qPCR sample prep, featuring viral RNA extraction reagent kits.

Contact Us

 

 

Helpful Links:

Extraction Kits:
RNAdvance Viral
RNAdvance Viral XP
Performance Data

Genomic Automated Workstations:
PCR Purification
RNA/DNA Extraction

 

Customer Spotlight
PDF Version:

    Warsaw Genomics Testimonial 

Download Spotlight

 

Performance Data:

  RNAdvance Viral and Viral XP Data Sheet Screenshot 

Download Data Sheet

 

White Paper:

White Paper: Characterization of RNAdvance Viral XP RNA Extraction Kit using AccuPlex™ SARS–CoV–2 Reference Material Kit

Download White Paper